Guideline on Screening for Esophageal Adenocarcinoma in Patients with Chronic Gastroesophageal Reflux Disease

Overview

Journal CMAJ

Date 2020 Jul 8

PMID 32631908

Citations 5

Authors

Stephane Groulx

Heather Limburg

Marion Doull

Scott Klarenbach

Harminder Singh

Brenda J Wilson

Brett Thombs

Affiliations

Soon will be listed here.

Citing Articles

Evidence summary on management strategies for gastroesophageal reflux symptoms in patients following esophageal cancer surgery.

Zhao Y, Fu Y, Zhang W, Zhao S, Li H Asia Pac J Oncol Nurs. 2025; 12():100639.

PMID: 39811449 PMC: 11732502. DOI: 10.1016/j.apjon.2024.100639.

Efficacy and safety of tegoprazan in the treatment of gastroesophageal reflux disease: A protocol for meta-analysis and systematic review.

Zheng H, Yuan S, Liu J PLoS One. 2024; 19(5):e0302450.

PMID: 38696509 PMC: 11065240. DOI: 10.1371/journal.pone.0302450.

Dissemination and implementation of clinical practice guidelines: a longitudinal, mixed-methods evaluation of the Canadian Task Force on Preventive Health Care's knowledge translation efforts.

Fahim C, Prashad A, Silveira K, Chandraraj A, Thombs B, Tonelli M CMAJ Open. 2023; 11(4):E684-E695.

PMID: 37553226 PMC: 10414974. DOI: 10.9778/cmajo.20220121.

OToole D Can Fam Physician. 2021; 67(12):e326-e328.

PMID: 34906950 PMC: 8670651. DOI: 10.46747/cfp.6712e326.

Rapid recommendations: Updates from 2020 guidelines: part 1.

OToole D Can Fam Physician. 2021; 67(12):912-914.

PMID: 34906940 PMC: 8670657. DOI: 10.46747/cfp.6712912.

References

Rubenstein J, Sonnenberg A, Davis J, McMahon L, Inadomi J . Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc. 2008; 68(5):849-55. PMC: 3481546. DOI: 10.1016/j.gie.2008.02.062. View

Zaman A, Hahn M, Hapke R, Knigge K, Fennerty M, Katon R . A randomized trial of peroral versus transnasal unsedated endoscopy using an ultrathin videoendoscope. Gastrointest Endosc. 1999; 49(3 Pt 1):279-84. DOI: 10.1016/s0016-5107(99)70001-5. View

Wenker T, Tan M, Liu Y, El-Serag H, Thrift A . Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival. Dig Dis Sci. 2018; 63(11):3112-3119. PMC: 6185782. DOI: 10.1007/s10620-018-5241-y. View

Sami S, Ragunath K, Iyer P . Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions. Clin Gastroenterol Hepatol. 2014; 13(4):623-34. PMC: 4254386. DOI: 10.1016/j.cgh.2014.03.036. View

Rubenstein J, Taylor J . Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2010; 32(10):1222-7. PMC: 3481544. DOI: 10.1111/j.1365-2036.2010.04471.x. View

Hammad T, Thrift A, El-Serag H, Husain N . Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma. Dig Dis Sci. 2018; 64(2):367-372. PMC: 6358496. DOI: 10.1007/s10620-018-5336-5. View

Bennett C, Moayyedi P, Corley D, deCaestecker J, Falck-Ytter Y, Falk G . BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015; 110(5):662-82. PMC: 4436697. DOI: 10.1038/ajg.2015.55. View

Fitzgerald R, di Pietro M, Ragunath K, Ang Y, Kang J, Watson P . British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2013; 63(1):7-42. DOI: 10.1136/gutjnl-2013-305372. View

Wani S, Rubenstein J, Vieth M, Bergman J . Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology. 2016; 151(5):822-835. DOI: 10.1053/j.gastro.2016.09.040. View

10.

Runge T, Abrams J, Shaheen N . Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2015; 44(2):203-31. PMC: 4449458. DOI: 10.1016/j.gtc.2015.02.001. View

11.

Roth L, Adams P . Variation in physician reimbursement for endoscopy across Canada. Can J Gastroenterol. 2009; 23(7):503-5. PMC: 2722471. DOI: 10.1155/2009/345719. View

12.

Leddin D, Armstrong D, Borgaonkar M, Bridges R, Fallone C, Telford J . The 2012 SAGE wait times program: Survey of Access to GastroEnterology in Canada. Can J Gastroenterol. 2013; 27(2):83-9. PMC: 3731118. DOI: 10.1155/2013/143018. View

13.

Singh S, Manickam P, Amin A, Samala N, Schouten L, Iyer P . Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2014; 79(6):897-909.e4. DOI: 10.1016/j.gie.2014.01.009. View

14.

Jankowski J, De Caestecker J, Love S, Reilly G, Watson P, Sanders S . Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial. Lancet. 2018; 392(10145):400-408. PMC: 6083438. DOI: 10.1016/S0140-6736(18)31388-6. View

15.

Jobe B, Hunter J, Chang E, Kim C, Eisen G, Robinson J . Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison. Am J Gastroenterol. 2007; 101(12):2693-703. DOI: 10.1111/j.1572-0241.2006.00890.x. View

16.

Paterson W, Barkun A, Hopman W, Leddin D, Pare P, Petrunia D . Wait times for gastroenterology consultation in Canada: the patients' perspective. Can J Gastroenterol. 2010; 24(1):28-32. PMC: 2830638. DOI: 10.1155/2010/912970. View

17.

Reid B, Li X, Galipeau P, Vaughan T . Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer. 2010; 10(2):87-101. PMC: 2879265. DOI: 10.1038/nrc2773. View

18.

Vakil N, van Zanten S, Kahrilas P, Dent J, Jones R . The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101(8):1900-20. DOI: 10.1111/j.1572-0241.2006.00630.x. View

19.

Desai T, Krishnan K, Samala N, Singh J, Cluley J, Perla S . The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut. 2011; 61(7):970-6. DOI: 10.1136/gutjnl-2011-300730. View

20.

Mori A, Ohashi N, Yoshida A, Nozaki M, Tatebe H, Okuno M . Unsedated transnasal ultrathin esophagogastroduodenoscopy may provide better diagnostic performance in gastroesophageal reflux disease. Dis Esophagus. 2010; 24(2):92-8. DOI: 10.1111/j.1442-2050.2010.01098.x. View